Found: 3
Select item for more details and to access through your institution.
Author Correction to: Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson's Disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson's Disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Randomized, placebo‐controlled trial of ADS‐5102 (amantadine) extended‐release capsules for levodopa‐induced dyskinesia in Parkinson's disease (EASE LID 3).
- Published in:
- Movement Disorders, 2017, v. 32, n. 12, p. 1701, doi. 10.1002/mds.27131
- By:
- Publication type:
- Article